|
Ramos-Molina B, Lambertos A, Peñafiel R. Antizyme Inhibitors in Polyamine Metabolism and Beyond: Physiopathological Implications. Med Sci (Basel). 2018 Oct 9;6(4). pii: E89. doi: 10.3390/medsci6040089. Review. PubMed PMID: 30304856; PubMed Central PMCID: PMC6313458.
AÑO: 2018
|
30304856
|
Acosta-Andrade C, Lambertos A, Urdiales JL, Sánchez-Jiménez F, Peñafiel R, Fajardo I. A novel role for antizyme inhibitor 2 as a regulator of serotonin and histamine biosynthesis and content in mouse mast cells. Amino Acids. 2016 Oct;48(10):2411-21. doi: 10.1007/s00726-016-2230-3. Epub 2016 Apr 15. PubMed PMID: 27084713.
AÑO: 2016; IF: 3.173
|
|
Cremades A, Del Rio-Garcia J, Lambertos A, López-Garcia C, Peñafiel R. Tissue-specific regulation of potassium homeostasis by high doses of cationic amino acids. Springerplus. 2016 May 13;5:616. doi: 10.1186/s40064-016-2224-3. eCollection 2016. PubMed PMID: 27330882; PubMed Central PMCID: PMC4870509.
AÑO: 2016; IF: 1.13
|
|
Ramos-Molina B, López-Contreras AJ, Lambertos A, Dardonville C, Cremades A, Peñafiel R. Influence of ornithine decarboxylase antizymes and antizyme inhibitors on agmatine uptake by mammalian cells. Amino Acids. 2015 May;47(5):1025-34. doi: 10.1007/s00726-015-1931-3. PubMed PMID: 25655388.
AÑO: 2015; IF: 3.063
|
|
Ramos-Molina B, Lambertos A, Lopez-Contreras AJ, Kasprzak JM, Czerwoniec A, Bujnicki JM, Cremades A, Peñafiel R. Structural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2. FEBS Open Bio. 2014 Jun 2;4:510-21. doi: 10.1016/j.fob.2014.05.004. PubMed PMID: 24967154; PubMed Central PMCID: PMC4066113.
AÑO: 2014; IF: 2.231
|